Literature DB >> 26930003

A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.

M Payrits1, É Sághy2, P Mátyus3, A Czompa4, R Ludmerczki5, R Deme6, Z Sándor7, Zs Helyes8, É Szőke9.   

Abstract

Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1, TRPV1) ion channels expressed on nociceptive primary sensory neurons are important regulators of pain and inflammation. TRPA1 is activated by several inflammatory mediators including formaldehyde and methylglyoxal that are products of the semicarbazide-sensitive amine-oxidase enzyme (SSAO). SZV-1287 is a new 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime SSAO inhibitor, its chemical structure is similar to other oxime derivatives described as TRPA1 antagonists. Therefore, we investigated its effects on TRPA1 and TRPV1 receptor activation on the cell bodies and peripheral terminals of primary sensory neurons and TRPA1 or TRPV1 receptor-expressing cell lines. Calcium influx in response to the TRPA1 agonist allyl-isothiocyanate (AITC) (200 μM) and the TRPV1 stimulator capsaicin (330 nM) in rat trigeminal neurons or TRPA1 and TRPV1 receptor-expressing cell lines was measured by microfluorimetry or radioactive (45)Ca(2+) uptake experiments. Calcitonin gene-related peptide (CGRP) release as the indicator of 100 μM AITC - or 100 nM capsaicin-induced peripheral sensory nerve terminal activation was measured by radioimmunoassay. SZV-1287 (100, 500 and 1000 nM) exerted a concentration-dependent significant inhibition on both AITC- and capsaicin-evoked calcium influx in trigeminal neurons and TRPA1 or TRPV1 receptor-expressing cell lines. It also significantly inhibited the TRPA1, but not the TRPV1 activation-induced CGRP release from the peripheral sensory nerve endings in a concentration-dependent manner. In contrast, the reference SSAO inhibitor LJP 1207 with a different structure had no effect on TRPA1 or TRPV1 activation in either model system. This is the first evidence that our novel oxime compound SZV-1287 originally developed as a SSAO inhibitor has a potent dual antagonistic action on TRPA1 and TRPV1 ion channels on primary sensory neurons.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SZV-1287; Transient Receptor Potential Ankyrin 1 and Vanilloid 1 receptors; allyl-isothiocyanate; capsaicin; semicarbazide-sensitive amine-oxidase; sensory neuron

Mesh:

Substances:

Year:  2016        PMID: 26930003     DOI: 10.1016/j.neuroscience.2016.02.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  PO-322 exerts potent immunosuppressive effects in vitro and in vivo by selectively inhibiting SGK1 activity.

Authors:  Yi Lai; Xing-Yan Luo; Hui-Jie Guo; Si-Yu Wang; Jing Xiong; Shu-Xia Yang; Li-Mei Li; Qiang Zou; Chun-Fen Mo; Yan-Tang Wang; Yang Liu
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

2.  Synthesis and In-Vivo Evaluation of Benzoxazole Derivatives as Promising Anti-Psoriatic Drugs for Clinical Use.

Authors:  Rami Ayoub; Jamal Jilani; Qais Jarrar; Raad Alani; Chrismawan Ardianto; Khang Wen Goh; Dalia Ali; Said Moshawih
Journal:  Molecules       Date:  2022-05-08       Impact factor: 4.927

3.  Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.

Authors:  Ádám Horváth; Awt Menghis; Bálint Botz; Éva Borbély; Ágnes Kemény; Valéria Tékus; Janka Zsófia Csepregi; Attila Mócsai; Tamás Juhász; Róza Zákány; Dóra Bogdán; Péter Mátyus; Julie Keeble; Erika Pintér; Zsuzsanna Helyes
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

Review 4.  Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential.

Authors:  Igor A Schepetkin; Mark B Plotnikov; Andrei I Khlebnikov; Tatiana M Plotnikova; Mark T Quinn
Journal:  Biomolecules       Date:  2021-05-22

Review 5.  Human Copper-Containing Amine Oxidases in Drug Design and Development.

Authors:  Serhii Vakal; Sirpa Jalkanen; Käthe M Dahlström; Tiina A Salminen
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

Review 6.  Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.

Authors:  Marko Salmi; Sirpa Jalkanen
Journal:  Antioxid Redox Signal       Date:  2017-12-07       Impact factor: 8.401

7.  Proof-of-Concept for the Analgesic Effect and Thermoregulatory Safety of Orally Administered Multi-Target Compound SZV 1287 in Mice: A Novel Drug Candidate for Neuropathic Pain.

Authors:  Ádám István Horváth; Nikolett Szentes; Valéria Tékus; Maja Payrits; Éva Szőke; Emőke Oláh; András Garami; Eszter Fliszár-Nyúl; Miklós Poór; Cecília Sár; Tamás Kálai; Szilárd Pál; Krisztina Percze; Éva Nagyné Scholz; Tamás Mészáros; Blanka Tóth; Péter Mátyus; Zsuzsanna Helyes
Journal:  Biomedicines       Date:  2021-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.